Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth.

Huang CC, Stricher F, Martin L, Decker JM, Majeed S, Barthe P, Hendrickson WA, Robinson J, Roumestand C, Sodroski J, Wyatt R, Shaw GM, Vita C, Kwong PD.

Structure. 2005 May;13(5):755-68.

PMID:
15893666
[PubMed - indexed for MEDLINE]
Free Article
2.

HIV gp120: double lock strategy foils host defences.

Sattentau QJ.

Structure. 1998 Aug 15;6(8):945-9. Review.

PMID:
9739096
[PubMed - indexed for MEDLINE]
3.

CD4-induced epitopes in the HIV envelope glycoprotein, gp120.

DeVico AL.

Curr HIV Res. 2007 Nov;5(6):561-71. Review.

PMID:
18045112
[PubMed - indexed for MEDLINE]
4.

From receptor recognition mechanisms to bioinspired mimetic antagonists in HIV-1/cell docking.

Dowd CS, Zhang W, Li C, Chaiken IM.

J Chromatogr B Biomed Sci Appl. 2001 Apr 5;753(2):327-35. Review.

PMID:
11334348
[PubMed - indexed for MEDLINE]
5.

HIV-1 entry inhibitors in the side pocket.

Sodroski JG.

Cell. 1999 Oct 29;99(3):243-6. Review. No abstract available.

PMID:
10555140
[PubMed - indexed for MEDLINE]
Free Article
6.

Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor.

Vermeire K, Schols D.

Expert Opin Investig Drugs. 2005 Oct;14(10):1199-212. Review.

PMID:
16185162
[PubMed - indexed for MEDLINE]
7.

Conformational properties of HIV-1 gp120/V3 immunogenic domains.

Galanakis PA, Spyroulias GA, Rizos A, Samolis P, Krambovitis E.

Curr Med Chem. 2005;12(13):1551-68. Review.

PMID:
15974987
[PubMed - indexed for MEDLINE]
8.

HIV-1 gp120 V3 loop for structure-based drug design.

Sirois S, Sing T, Chou KC.

Curr Protein Pept Sci. 2005 Oct;6(5):413-22. Review.

PMID:
16248793
[PubMed - indexed for MEDLINE]
9.

Design of miniproteins by the transfer of active sites onto small-size scaffolds.

Stricher F, Martin L, Vita C.

Methods Mol Biol. 2006;340:113-49. Review.

PMID:
16957335
[PubMed - indexed for MEDLINE]
10.

CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target.

Sweet RW, Truneh A, Hendrickson WA.

Curr Opin Biotechnol. 1991 Aug;2(4):622-33. Review.

PMID:
1367682
[PubMed - indexed for MEDLINE]
11.

CD4 antagonists.

McKeating JA.

Biochem Soc Trans. 1992 May;20(2):521-5. Review. No abstract available.

PMID:
1397653
[PubMed - indexed for MEDLINE]
12.

Novel miniproteins engineered by the transfer of active sites to small natural scaffolds.

Vita C, Vizzavona J, Drakopoulou E, Zinn-Justin S, Gilquin B, Ménez A.

Biopolymers. 1998;47(1):93-100. Review.

PMID:
9692330
[PubMed - indexed for MEDLINE]
13.

Synthetic neoglycolipids for biological applications: correlation between their structures and their interactions with membrane proteins.

Rico-Lattes I, Gouzy MF, Andre-Barres C, Guidetti B, Lattes A.

Biochimie. 1998 May-Jun;80(5-6):483-7. Review.

PMID:
9782388
[PubMed - indexed for MEDLINE]
14.

Interleukin 16 and its function as a CD4 ligand.

Center DM, Kornfeld H, Cruikshank WW.

Immunol Today. 1996 Oct;17(10):476-81. Review. No abstract available.

PMID:
8908813
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk